Consistent with these findings, transgenic CaMKII overexpression in the mouse leads to development of heart failure, while CaMKII deletion prevents onset of heart failure following transaortic constriction (Maier et al., 2003; Zhang et al., 2003; Backs et al., 2009; Ling et al., 2009). This evidence concerns the gene CAMK2G and heart failure.